SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Achaogen (AKAO)

Add AKAO Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 10/7/2016 9:21:23 AM - Followers: 13 - Board type: Free - Posts Today: 0

Company Overview

Achaogen is a clinical-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant, or MDR, gram-negative infections.

Achaogen (a-KAY-o-jen) is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae, or CRE. In 2013, the Centers for Disease Control and Prevention identified CRE as a “nightmare bacteria” and an immediate public health threat that requires “urgent and aggressive action.” We expect to initiate a Phase 3 superiority trial of plazomicin in the first quarter of 2014.

CRE are one of many types of MDR gram-negative pathogens threatening patients. Bacteria such as Pseudomonas aeruginosa, Acinetobacter baumannii, and extended-spectrum beta-lactamase producing Enterobacteriaceae each pose “serious” resistance threats, according to the CDC, and also drive a great need for new, safe, and effective antibiotics. We have assembled the chemistry and microbiology expertise and capabilities required to develop new agents for the treatment of gram-negative infections. Plazomicin was the first clinical candidate from our gram-negative antibiotic discovery engine. In addition, our research and development pipeline includes two antipseudomonal programs targeting P. aeruginosa—a program to discover and develop small molecule inhibitors of LpxC, which is an enzyme essential for the synthesis of the outer membrane of gram-negative bacteria, and a therapeutic antibody program. We are also pursuing small molecule research programs targeting other essential gram-negative enzymes.

Achaogen has built an exceptional research and development team with deep expertise in the discovery and development of new drugs from research through commercialization. Our executive team has over 60 years of combined industry experience, and a proven track record of leadership, global registration, and lifecycle management for over 20 products. Our facility is located on the shores of the San Francisco Bay, ten minutes from the San Francisco International Airport, and only fifteen minutes from downtown San Francisco.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
AKAO News: Quarterly Report (10-q) 11/07/2016 04:07:58 PM
AKAO News: Confidential Treatment Order (ct Order) 10/04/2016 04:14:33 PM
AKAO News: Statement of Changes in Beneficial Ownership (4) 09/29/2016 07:38:46 PM
AKAO News: Statement of Changes in Beneficial Ownership (4) 09/29/2016 07:37:56 PM
AKAO News: Current Report Filing (8-k) 09/01/2016 04:03:40 PM
#32   Shorty on sideline more accumulation and upward price movement itsabouttime 10/07/16 09:21:23 AM
#31   And any idea why the drop from 52 BostonBull1990 06/02/16 07:04:43 PM
#30   Does anyone know the share structure? Why isn't BostonBull1990 06/02/16 07:03:48 PM
#29   * * $AKAO Video Chart 06-02-16 * * ClayTrader 06/02/16 05:07:58 PM
#28   Need some buying pressure to get this back BostonBull1990 06/02/16 11:37:11 AM
#27   GOOD MORNING AKAO!!! jaytea 06/02/16 09:39:29 AM
#26   AKAO..7.21 Still a low market cap: 130.86M flare9x 07/22/15 12:12:36 PM
#25   AKAO..6.81 Achaogen Awarded $4.5 Million Contract With NIAID flare9x 07/16/15 07:46:15 AM
#24   $AKAO recent news/filings stocktrademan 07/15/15 02:42:32 PM
#23   AKAO..6.20 House Approves Roskam Legislation to Combat Superbugs flare9x 07/10/15 02:41:36 PM
#22   Institutions own approx 60%+ of the outstanding shares. flare9x 07/08/15 04:40:33 PM
#21   With phase 3 results not expected for another Rob_ 07/08/15 02:55:51 PM
#20   AKAO DD..5.91 flare9x 07/08/15 02:03:38 PM
#19   $AKAO captainscotty 05/18/15 07:25:42 AM
#18   Thanks for the commentary, but AKAO never was THREE-DAY-TRADER 05/15/15 11:31:24 PM
#17   When is this thing supposed to shoot up? Mkelly0129 05/15/15 08:56:25 PM
#16   Why Earnings Season Could Be Great for Achaogen, richdad813 05/08/15 12:58:41 PM
#15   Listed at my profile THREE-DAY-TRADER 05/07/15 10:06:49 AM
#14   Yeah sorry just figured no ones on here Mkelly0129 05/07/15 07:26:17 AM
#13   Thanks!!! Yes, we flipped NRTI & also RXII. THREE-DAY-TRADER 05/06/15 11:46:02 PM
#12   I know you're not ignorant I was just Mkelly0129 05/06/15 09:42:20 PM
#11   It can run up a few days into THREE-DAY-TRADER 05/06/15 09:36:16 PM
#10   You're calling ONTY so close to earnings? Smart Mkelly0129 05/06/15 09:30:45 PM
#9   LOL)) Yep, you are right on about trading THREE-DAY-TRADER 05/04/15 08:07:05 PM
#8   You're getting slammed in NRTI board lol sore Mkelly0129 05/04/15 07:59:26 PM
#7   Mainly caused by 'volatility' on the drop. THREE-DAY-TRADER 04/25/15 10:13:32 PM
#6   Yeah I'm not looking long term on this..Thanks Mkelly0129 04/25/15 03:22:52 PM
#5   Current CASH on balance sheet you want to THREE-DAY-TRADER 04/25/15 03:02:38 PM
#4   When you say cash you mean working capital? Mkelly0129 04/25/15 01:46:07 PM
#3   It is good for cash, so all I THREE-DAY-TRADER 04/25/15 01:37:43 PM
#2   Definite bottom going to take a position in Mkelly0129 04/25/15 01:14:33 PM
#1   AKAO looks like today was possible bottom, based THREE-DAY-TRADER 04/23/15 10:15:47 PM